TREX1-Associated Familial Chilblain Lupus With Cerebral Aneurysms Treated With Janus Kinase Inhibition
Open Access
- 1 February 2025
- journal article
- Published by The Journal of Rheumatology in The Journal of Rheumatology
Abstract
Familial chilblain lupus (FCL) is a rare monogenic interferonopathy associated with multiple genetic mutations, including TREX1, characterized by painful, bluish-red skin lesions on acral areas, typically after cold exposure.1-3 Associated symptoms include inflammatory arthritis, cytopenias, antinuclear antibody (ANA) positivity, and rarely, cerebral aneurysms.4,5Keywords
This publication has 6 references indexed in Scilit:
- JAK inhibition in the type I interferonopathiesJournal of Allergy and Clinical Immunology, 2021
- Familial chilblain lupus with TREX1 mutation and cerebrovascular diseaseThe Lancet Rheumatology, 2020
- A TREX1 mutation causing cerebral vasculopathy in a patient with familial chilblain lupusJournal of Neurology, 2013
- A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupusJournal of Molecular Medicine, 2007
- Heterozygous Mutations in TREX1 Cause Familial Chilblain Lupus and Dominant Aicardi-Goutières SyndromeThe American Journal of Human Genetics, 2007
- Familial Chilblain Lupus, a Monogenic Form of Cutaneous Lupus Erythematosus, Maps to Chromosome 3pThe American Journal of Human Genetics, 2006